Scholarly Index
Deborah A. Fisher
Eli Lilly (United States); 9,592 total citations; 211 total publications; best world rank #341
Eli Lilly (United States)
9,592Total citations
211Total publications
41H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Gastric Cancer Management and Outcomes | Lifetime | 953 | US 282 | 98.22 |
| Colorectal Cancer Screening and Detection | Lifetime | 638 | US 282 | 97.72 |
| Esophageal and GI Pathology | Lifetime | 982 | US 431 | 97.10 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 794 | US 217 | 90.30 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 341 | US 96 | 94.82 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 747 | US 129 | 94.80 |
| Genetic factors in colorectal cancer | 2021-2025 | 432 | US 158 | 92.46 |
| Diverticular Disease and Complications | 2021-2025 | 389 | US 103 | 83.58 |